T cells are a type of white blood cell that can ‘remember’ antigens for decades. Vaccines developed using this new approach may provide more lasting protection.
Current vaccines target the spike protein of SARS-CoV-2. This protein mutates frequently, which could make currently available vaccines less effective.
Researchers in the United States recently investigated the effects of T cells that recognize a different protein in the virus — one that does not mutate as quickly as the spike protein.
https://www.medicalnewstoday.com/article...the-future
Current vaccines target the spike protein of SARS-CoV-2. This protein mutates frequently, which could make currently available vaccines less effective.
Researchers in the United States recently investigated the effects of T cells that recognize a different protein in the virus — one that does not mutate as quickly as the spike protein.
https://www.medicalnewstoday.com/article...the-future